{'52WeekChange': -0.32198745,
 'SandP52WeekChange': 0.0644362,
 'address1': '200 Minuteman Road',
 'address2': 'Suite 302',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 18,
 'askSize': 800,
 'averageDailyVolume10Day': 149025,
 'averageVolume': 193485,
 'averageVolume10days': 149025,
 'beta': None,
 'beta3Year': None,
 'bid': 16.75,
 'bidSize': 1100,
 'bookValue': 2.187,
 'category': None,
 'circulatingSupply': None,
 'city': 'Andover',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 17.6657,
 'dayLow': 17.02,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': -10.951,
 'enterpriseToRevenue': 12.545,
 'enterpriseValue': 331910016,
 'exDividendDate': None,
 'exchange': 'NGM',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fiftyDayAverage': 16.740572,
 'fiftyTwoWeekHigh': 26.29,
 'fiftyTwoWeekLow': 10.1,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 15059867,
 'forwardEps': -0.92,
 'forwardPE': -18.836956,
 'fromCurrency': None,
 'fullTimeEmployees': 109,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'heldPercentInsiders': 0.23261999,
 'heldPercentInstitutions': 0.76489997,
 'industry': 'Medical Devices',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577491200,
 'lastMarket': None,
 'lastSplitDate': None,
 'lastSplitFactor': None,
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/transmedics.com',
 'longBusinessSummary': 'TransMedics Group, Inc., a commercial-stage medical '
                        'technology company, engages in transforming organ '
                        'transplant therapy for end-stage organ failure '
                        'patients in the United States and internationally. '
                        'The company offers Organ Care System (OCS), a '
                        'portable organ perfusion, optimization, and '
                        'monitoring system that utilizes its proprietary and '
                        'customized technology to replicate near-physiologic '
                        'conditions for donor organs outside of the human '
                        'body. Its Organ Care System includes OCS LUNG, a '
                        'portable perfusion apparatus, optimization, and '
                        'monitoring system that maintains the organ at a '
                        'near-physiologic state allowing physicians to assess '
                        'and improve the condition of lungs between the donor '
                        'and recipient sites; OCS Heart, a portable, warm '
                        'perfusion, and monitoring system designed to keep a '
                        'donor heart at a human-like, metabolically active '
                        'state; and OCS Liver, a system that is evaluated in '
                        'clinical trials for utilized and unutilized donor '
                        'livers. TransMedics Group, Inc. was founded in 1998 '
                        'and is headquartered in Andover, Massachusetts.',
 'longName': 'TransMedics Group, Inc.',
 'market': 'us_market',
 'marketCap': 469842304,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_429233',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': -35504000,
 'nextFiscalYearEnd': 1640649600,
 'open': 17.36,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': None,
 'phone': '978 552 0900',
 'previousClose': 17.57,
 'priceHint': 2,
 'priceToBook': 7.9240966,
 'priceToSalesTrailing12Months': 17.758043,
 'profitMargins': -1.3419,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 17.6657,
 'regularMarketDayLow': 17.02,
 'regularMarketOpen': 17.36,
 'regularMarketPreviousClose': 17.57,
 'regularMarketPrice': 17.36,
 'regularMarketVolume': 55924,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 27111500,
 'sharesPercentSharesOut': 0.048499998,
 'sharesShort': 1314580,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 2024103,
 'shortName': 'TransMedics Group, Inc.',
 'shortPercentOfFloat': 0.0704,
 'shortRatio': 5.48,
 'startDate': None,
 'state': 'MA',
 'strikePrice': None,
 'symbol': 'TMDX',
 'threeYearAverageReturn': None,
 'toCurrency': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': -1.853,
 'twoHundredDayAverage': 16.278202,
 'volume': 55924,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.transmedics.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '01810'}